News, Analysis, Trends, Management Innovations for
Clinical Laboratories and Pathology Groups

Hosted by Robert Michel

News, Analysis, Trends, Management Innovations for
Clinical Laboratories and Pathology Groups

Hosted by Robert Michel
Sign In

May 2016 Speaker Bios

Troy Moore

Troy Moore,
Chief Technology Officer,
Kailos Genetics, Inc.,
Huntsville, AL

Mr. Troy Moore is Kailos Genetics’ CTO. Mr. Moore brings over 20 years of experience in the development of biotechnology companies. He was a co-founder of Open Biosystems in 2002 where he served as the Chief Technology Officer until the company was acquired by ThermoFisher Scientific in 2008. As the company’s CTO, Mr. Moore was responsible for the development of new products, technology licensing and collaborative research. Previously, he was the Director of Genomic Resources at Invitrogen following their acquisition of Research Genetics in 2000. At Research Genetics, Mr. Moore was the Director of Genomic Libraries with responsibilities for technology licensing, new product development and whole genome resource distribution, domestic and international. Prior to joining Research Genetics, Troy participated in academic research focused on natural product development.

 


Tom Schoenherr

Tom Schoenherr,
Chief Commercial Officer,
Counsyl, Inc.,
South San Francisco, CA

Tom’s primary focus at Counsyl is on the commercial strategy, development and execution for his organization. He is responsible for activities relating to marketing, sales, business development, health plans and customer service in order to drive business growth and market share. As a member of the Senior Management Team at Counsyl, Tom’s main concern is ensuring the integrated commercial success of the organization. Tom has over 20 years’ experience and demonstrated performance excellence in the medical diagnostics and services industry. Prior to joining Counsyl, Tom held multiple executive leadership positions with Abbott Diagnostics, Siemens Diagnostics, and Quest Diagnostics.

;